The leader of the Triad’s second-largest public company and only member of the Fortune 500, Schechter has led Labcorp to ...

Labcorp announced it will offer the nation's first blood test cleared by the FDA for the initial assessment in Alzheimer's ...

Quest Diagnostics Incorporated shows post-pandemic growth with Q3 results, strategic expansion, and steady returns. Click for ...

Praia Health’s latest announcements aim to boost patient engagement across health systems by streamlining data and operations ...

Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the only blood test cleared by the U.S. Food and Drug ...

Labcorp Holdings Inc. closed 4.84% short of its 52-week high of $293.72, which the company reached on October 21st.

Labcorp announced it will begin offering the Elecsys pTau181 blood test nationwide by early 2026, making available the only FDA-cleared blood test in the U.S. to aid in the initial assessment for ...

The Burlington, N.C., lab-services company on Thursday said the Elecsys pTau181 test, developed by Swiss drugmaker Roche Holding and approved for commercialization by the U.S. Food and Drug ...

New case study shows how a streamlined digital experience improved lab order adherence, reduced no-shows, and enhanced ...

BURLINGTON, N.C. - Labcorp (NYSE:LH), a prominent healthcare diagnostics provider with a market capitalization of $23.5 billion, announced Thursday it will offer the Elecsys pTau181 test nationwide by ...

Over 141,000 bottles of cholesterol medication have been recalled due to “failed dissolution specifications,” suggesting that ...